SCHEMBL8004976

SCHEMBL8004976

Cc1cc(C)c(NC(=O)Nc2ccncc2)c(C)c1

nearest known ligand 0.63

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MDM2 Q00987 1/20 0.63
KMT2A Q03164 4/20 0.62
PKM P14618 1/20 0.62
SMN1; SMN2 Q16637 1/20 0.62
TAAR1 Q96RJ0 2/20 0.56
ATM Q13315 1/20 0.54
MAPT P10636 2/20 0.53
TP53 P04637 1/20 0.53
MEN1 O00255 3/20 0.53
RAB9A P51151 1/20 0.53
SMARCA2 P51531 1/20 0.51
SMARCA4 P51532 1/20 0.51
CCNC P24863 1/20 0.51
CDK8 P49336 1/20 0.51
ALDH1A1 P00352 1/20 0.50
LCK P06239 1/20 0.49
IMPDH2 P12268 1/20 0.49
NT5E P21589 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8017826 0.87 MDM2 (0.59) MDM2KMT2APKMSMN1; SMN2TAAR1
SCHEMBL8020585 0.85 MDM2 (0.66) MDM2KMT2APKMSMN1; SMN2TAAR1
SCHEMBL4448022 0.82 ALDH1A1 (0.65) KMT2AATMMAPTTP53MEN1
SCHEMBL8013378 0.81 NPC1 (0.68) KMT2ATAAR1ATMMAPTMEN1
SCHEMBL5851814 0.80 MDM2 (0.76) MDM2KMT2APKMSMN1; SMN2TAAR1
SCHEMBL4548130 0.80 CNR1 (0.58) KMT2ASMN1; SMN2ATMMAPTTP53
SCHEMBL16857521 0.80 MAPT (0.63) KMT2APKMATMMAPTTP53
SCHEMBL10020286 0.80 MDM2 (1.00) MDM2KMT2APKMSMN1; SMN2TAAR1
SCHEMBL5640290 0.78 NAMPT (0.53) MDM2KMT2APKMSMN1; SMN2RAB9A
SCHEMBL31610791 0.78 TYK2 (0.59) MDM2KMT2APKMSMN1; SMN2NT5E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0135335-B1 N-(2,6-DISUBSTITUTED AROMATIC)-N'-PYRIDINYL UREAS, PROCESSES FOR THEIR PRODUCTION AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME WARNER-LAMBERT COMPANY (US) 1989-11-08 EP claimed
US-4629731-A Anticonvulsant N-(2,6-disubstituted aromatic)-n'-pyridinyl ureas WARNER-LAMBERT COMPANY (US) 1986-12-16 US claimed
EP-0135335-A2 N-(2,6-disubstituted aromatic)-N'-pyridinyl ureas, processes for their production and pharmaceutical compositions comprising the same WARNER-LAMBERT COMPANY (US) 1985-03-27 EP claimed
US-6133299-A ADMINISTERING TO A MAMMAL A COMPOUND SELECTED FROM RALITOLINE, PHENYTOIN, LAMOTRIGINE, CARBAMAZEPINE, LIDOCAINE OR TETRODOTOXIN; TREATING DISEASE SUCH AS STROKE, ALZHEIMER'S DISEASE, HUNTINGTON'S DISEASE, PARKINSON'S DISEASE WARNER-LAMBERT COMPANY (US) 2000-10-17 US disclosed
WO-1994018972-A2 METHODS FOR TREATING NEURODEGENERATIVE DISEASES AND DISORDERS USING N-(2,6-DISUBSTITUTED AROMATIC)-N'-PYRIDINYL UREAS AND OTHER ANTICONVULSANT COMPOUNDS WARNER-LAMBERT COMPANY (US) 1994-09-01 WO disclosed
US-4962116-A ANTICONVULSANTS, ANTIEPILEPTIC AGENTS WARNER-LAMBERT COMPANY (US) 1990-10-09 US disclosed
EP-0135335-B1 N-(2,6-DISUBSTITUTED AROMATIC)-N'-PYRIDINYL UREAS, PROCESSES FOR THEIR PRODUCTION AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME WARNER-LAMBERT COMPANY (US) 1989-11-08 EP disclosed
US-4629731-A Anticonvulsant N-(2,6-disubstituted aromatic)-n'-pyridinyl ureas WARNER-LAMBERT COMPANY (US) 1986-12-16 US disclosed
EP-0135335-A2 N-(2,6-disubstituted aromatic)-N'-pyridinyl ureas, processes for their production and pharmaceutical compositions comprising the same WARNER-LAMBERT COMPANY (US) 1985-03-27 EP disclosed